v3.24.4
Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Revenues from product sales          
Net loss 591,021 $ (313,123) $ 634,100 1,774,189 $ 832,605 $ 1,747,250 911,998 4,354,044  
Net cash used in operations             215,225 319,816  
Working capital 5,680,342           5,680,342    
Working capital 24,494,502           24,494,502   $ 23,582,504
Cash FDIC insured amount 250,000           250,000   $ 250,000
Research and development costs $ 91,911     $ 239,458     $ 291,655 $ 710,063  
Divided percentage             70.00%   70.00%
Warrant [Member]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Anti dilutive securities             1,359,375   1,359,375
Restricted Stock Units (RSUs) [Member]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Anti dilutive securities             1,626,037   1,618,537
Share-Based Payment Arrangement, Option [Member]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Anti dilutive securities             10,633,988   10,336,882
Convertible Debt Securities [Member]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Anti dilutive securities             13   14